Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TOPAS-1, A Pharmacodynamic Phase II Study of Clopidogrel P2Y12 Platelet Inhibition

NCT00914368 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT00914368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00914368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TOPAS-1, A Pharmacodynamic Phase II Study of Clopidogrel P2Y12 Platelet Inhibition
Lead sponsor
Uppsala University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
March 31, 2010
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, coronary artery disease, heart diseases, myocardial infarction, stent thrombosis